Sildenafil Citrate NDC 70954-407

NDC codes

FDA NDC Directory

Product NDC (as listed)70954-407Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70954-0407Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70954-407-10	70954040710	30 TABLET in 1 BOTTLE (70954-407-10)Marketed from Aug 29, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sildenafil Citrate
Generic name (nonproprietary): sildenafil citrate
Active ingredients: Sildenafil citrate — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216383
Marketing start: Aug 29, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Phosphodiesterase 5 Inhibitors (Mechanism)
Identifiers: Product ID 70954-407_6d8dbaa6-d61a-46ae-a641-f664104f4714SPL ID 6d8dbaa6-d61a-46ae-a641-f664104f4714SPL set ID 6d8dbaa6-d61a-46ae-a641-f664104f4714RxCUI 312950, 314228, 314229UNII BW9B0ZE037UPC 0370954409106, 0370954407102, 0370954408109
Pharmacologic class: Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470954040710 followed by a unit qualifier and the quantity

Package 70954-0407-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 5, 2023.

Indications (excerpt from the label)

Sildenafil is indicated for the treatment of erectile dysfunction. Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216383

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216383
Product	Strength	Form · route	Labeler	Product NDC
Sildenafil Citrate	Sildenafil citrate 50 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-408
Sildenafil Citrate	Sildenafil citrate 100 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-409